Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure

Background: According to numerous studies, from 30% to 50% of patients with chronic heart failure (CHF) are resistant to cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM), despite their careful selection in accordance with current guidelines. It is of interest to stu...

Full description

Bibliographic Details

Published in:	Alʹmanah Kliničeskoj Mediciny
Main Authors:	N. B. Shlevkov, A. Zh. Gasparyan, A. A. Zhambeev, H. F. Salami, E. V. Guseva, G. S. Tarasovskiy, T. V. Sharf, O. V. Stukalova, E. M. Gupalo, N. A. Mironova, A. A. Skvortsov, S. P. Golitsyn
Format:	Article
Language:	Russian
Published:	MONIKI 2021-06-01
Subjects:	biomarkers nt-probnp sst2 chronic heart failure cardiac resynchronization therapy cardiac contractility modulation prognosis
Online Access:	https://www.almclinmed.ru/jour/article/view/1487